Sign in3 stories
Ginkgo said third-quarter revenue fell 6% to $28 million while losses narrowed, and disclosed an autonomous lab sale to Novo along with new government contracts.
SEC filing (2)
The company reported third-quarter 2026 results alongside an FDA submission, a trial closure expected to save up to $125 million, and $1.15 billion in cash.
SEC filing (14)
Harmony's board set a leadership transition effective January 1, 2027, while reaffirming 2026 WAKIX revenue guidance and a pipeline data readout.
SEC filing